RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cerevel Therapeutics Holdings Stock

Cerevel Therapeutics Holdings Debt 2024

Cerevel Therapeutics Holdings Debt

-79.04 USD

Ticker

CERE

ISIN

US15678U1280

WKN

A2QF3L

In 2024, Cerevel Therapeutics Holdings's total debt was -79.04 USD, a -139.72% change from the 199 USD total debt recorded in the previous year.

Cerevel Therapeutics Holdings Aktienanalyse

What does Cerevel Therapeutics Holdings do?

Cerevel Therapeutics Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Cerevel Therapeutics Holdings's Debt Structure

Cerevel Therapeutics Holdings's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Cerevel Therapeutics Holdings's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Cerevel Therapeutics Holdings’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Cerevel Therapeutics Holdings’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Cerevel Therapeutics Holdings stock

What is the debt of Cerevel Therapeutics Holdings this year?

Cerevel Therapeutics Holdings has a debt level of -79.04 USD this year.

What was the debt of Cerevel Therapeutics Holdings compared to the previous year?

The debt of Cerevel Therapeutics Holdings has increased by -139.72% compared to the previous year dropped.

What are the consequences of high debt for investors in Cerevel Therapeutics Holdings?

High debt can pose a risk for investors of Cerevel Therapeutics Holdings, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Cerevel Therapeutics Holdings?

Low debt means that Cerevel Therapeutics Holdings has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Cerevel Therapeutics Holdings affect the company?

An increase in debt of Cerevel Therapeutics Holdings can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Cerevel Therapeutics Holdings affect the company?

A reduction in debt of Cerevel Therapeutics Holdings can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Cerevel Therapeutics Holdings?

Some factors that can influence the debt of Cerevel Therapeutics Holdings include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Cerevel Therapeutics Holdings so important for investors?

The debts of Cerevel Therapeutics Holdings are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Cerevel Therapeutics Holdings take to change the debt?

To change the debt, Cerevel Therapeutics Holdings can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Cerevel Therapeutics Holdings pay?

Over the past 12 months, Cerevel Therapeutics Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cerevel Therapeutics Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Cerevel Therapeutics Holdings?

The current dividend yield of Cerevel Therapeutics Holdings is .

When does Cerevel Therapeutics Holdings pay dividends?

Cerevel Therapeutics Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cerevel Therapeutics Holdings?

Cerevel Therapeutics Holdings paid dividends every year for the past 0 years.

What is the dividend of Cerevel Therapeutics Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cerevel Therapeutics Holdings located?

Cerevel Therapeutics Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cerevel Therapeutics Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cerevel Therapeutics Holdings from 8/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/25/2024.

When did Cerevel Therapeutics Holdings pay the last dividend?

The last dividend was paid out on 8/25/2024.

What was the dividend of Cerevel Therapeutics Holdings in the year 2023?

In the year 2023, Cerevel Therapeutics Holdings distributed 0 USD as dividends.

In which currency does Cerevel Therapeutics Holdings pay out the dividend?

The dividends of Cerevel Therapeutics Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cerevel Therapeutics Holdings

Our stock analysis for Cerevel Therapeutics Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cerevel Therapeutics Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.